Vaccine

A vaccine is a biological preparation that improves immunity to a particular disease. A vaccine typically contains an agent that resembles a disease-causing microorganism, and is often made from weakened or killed forms of the microbe. The agent stimulates the body's immune system to recognize the agent as foreign, destroy it, and "remember" it, so that the immune system can more easily recognize and destroy any of these microorganisms that it later encounters.

What are Vaccines?

There are several diseases like Diphtheria, whooping cough (pertussis), measles, mumps, Yellow fever, small pox and German measles (rubella) that are unfamiliar to many these days.

Vaccine Immunity

What is a DNA Vaccine?

A New Breed of Vaccine: Exploring Doggybone ™ DNA Technology

How are Vaccines Stored?

What is the Importance of Vaccination Coverage?

Vaccination in Humanitarian Settings

The Future of Vaccines

The Big Catch-Up: How the COVID-19 pandemic impacted vaccination coverage

Role of Computer Modeling in Vaccine Development

Investigating the Importance of Investing in Vaccine Manufacturing

Hib Immunization

See more featured articles »

Vaccine Schedule

What is Immunobridging?

What is an Inactivated Vaccine?

What is a VLP Vaccine?

What are the Different Types of Vaccines?

Vaccine Production

Vaccine Effectiveness

What the Newest mRNA Vaccines Could Do Beyond COVID

What is a Non-Replicating Vaccine?

The Essential Program on Immunization is 50: Milestones, achievements, and future directions

What are Adenovirus-Based Vaccines?

Insight into Personalized Vaccines

Could there be a Salmonella Vaccine?

What are Nanoparticle-Based Vaccines?

What is a Subunit Vaccine?

Plant-Derived Vaccines

What is a Toxoid Vaccine?

What is a Vaccine Breakthrough?

What is an RNA Vaccine?

Vaccine Delivery

What are the Main Causes of Vaccine Hesitancy?

How Veterinary Vaccines Affect Human Health

What is a Live-Attenuated Vaccine?

Vaccine History

History of Vaccination

Immunization strategies: What lessons can we learn from successful campaigns?

Vaccine Excipients

Transforming Vaccine Design: The Promise of Systems Biology

Latest Vaccine News and Research

Study reveals complex patterns of burden and survival among people with digestive system cancers in China

Digestive system malignancies (DSMTs)-including esophageal, gastric, colorectal, liver, and pancreatic cancers-represent a major public health challenge in China.

18 Jul 2025

New mRNA vaccine strategy awakens immune system to fight cancer

An experimental mRNA vaccine boosted the tumor-fighting effects of immunotherapy in a mouse-model study, bringing researchers one step closer to their goal of developing a universal vaccine to "wake up" the immune system against cancer.

18 Jul 2025

Old chemistry unlocks safer and stronger mRNA delivery

As millions of people know firsthand, the most common side effect of mRNA vaccines like the COVID-19 shot is inflammation: soreness, redness and a day or two of malaise.

18 Jul 2025

COVID-19 boosters reduce hospitalization risk for cancer patients

Vaccine boosters help keep cancer patients from being hospitalized or admitted to intensive care units due to COVID-19, according to a new study led by Cedars-Sinai investigators.

17 Jul 2025

Aluminum vaccines cleared of long-term health risks

Findings from a cohort of 1.2 million children indicate aluminum-adsorbed vaccines do not raise the risk of autism, asthma, or autoimmune diseases.

17 Jul 2025

Vaccinated women face fewer cervical cancer risks

The HPV vaccine demonstrates strong long-term protection against cervical cancer, yet the study underscores the necessity of ongoing screening for all women.

17 Jul 2025

Measles outbreaks surge worldwide, driven by declining immunization coverage

The Global Virus Network (GVN), a coalition of leading human and animal virologists from 80+ Centers of Excellence and Affiliates in more than 40 countries, is sounding the alarm over a sharp resurgence of measles cases in the United States and globally.

17 Jul 2025

Prestigious Stephenson Scholar Grants support cutting-edge pancreatic cancer studies

The Stephenson Global Pancreatic Cancer Research Institute and its partner City of Hope, one of the country's largest and most advanced cancer research and treatment organizations, today announced the six inaugural recipients of the prestigious Stephenson Scholar Grants, awarding $5.25 million to support high-impact research aimed at transforming the understanding, early detection and treatment of pancreatic cancer.

16 Jul 2025

Fred Hutch leads national study on multi-cancer detection blood tests

Fred Hutch Cancer Center is leading the newly launched Vanguard Study, a national study of a new type of blood test that screens for several different cancers called multi-cancer detection (MCD) tests.

16 Jul 2025

NIST releases first publicly consented pancreatic cancer genome data

In an effort to foster progress in cancer research, the National Institute of Standards and Technology (NIST) is releasing detailed and comprehensive data about the entire genetic content of a pancreatic cancer cell.

16 Jul 2025

Routine vaccines may be the key to fighting antibiotic resistance

A study reveals that rising vaccine coverage in children is linked to reduced antibiotic prescriptions, suggesting a shift in the fight against drug resistance.

16 Jul 2025

UNM researchers get $1 million grant to launch early clinical trial for Alzheimer’s vaccine

University of New Mexico researchers have received funding to launch an early-stage clinical trial of a vaccine engineered to clear pathological tau protein from the brains of patients suffering from Alzheimer's dementia.

15 Jul 2025

TB bacteria can play dead to outlast the immune response, study reveals

A vaccine protects more than 100 million infants each year from severe tuberculosis (TB), including the fatal brain swelling it can cause in babies and toddlers.

15 Jul 2025

U.S. could safely end routine adult tetanus and diphtheria shots, review suggests

The United States could safely drop tetanus and diphtheria booster shots for adults and save an estimated $1 billion a year, according to a new review led by researchers at Oregon Health & Science University.

15 Jul 2025

WHO and UNICEF urge action to protect children through vaccines

In 2024, 89% of infants globally – about 115 million – received at least one dose of the diphtheria, tetanus and pertussis (DTP)-containing vaccine, and 85% – roughly 109 million – completed all three doses, according to new national immunization coverage data released today by the World Health Organization (WHO) and UNICEF.

15 Jul 2025

WEE1 identified as a key driver of immune resistance in cancer

Immune checkpoints are regulatory proteins that prevent the immune system from attacking healthy tissues.

15 Jul 2025

Light-activated drug discovery identifies broad-spectrum antivirals

UC Santa Barbara researchers and collaborators from campus biotech spinoff Integrated Biosciences, as well as Harvard, MIT and genomics company Illumina Ventures are using optogenetics - the use of light to probe the functions of living tissue - to find compounds to help our bodies more effectively help themselves in times of physiological stress.

15 Jul 2025

Many Americans turn to AI for health answers despite accuracy warnings

Traditionally, individuals asked health questions of their primary health care provider. Confidence in that provider as a source of trustworthy health information has been consistently high in recent years and was at 90% in April, according to survey data from the Annenberg Public Policy Center (APPC) of the University of Pennsylvania.

14 Jul 2025

New WHO guidelines recommend injectable lenacapavir for HIV prevention

The World Health Organization (WHO) released today new guidelines recommending the use of injectable lenacapavir (LEN) twice a year as an additional pre-exposure prophylaxis (PrEP) option for HIV prevention, in a landmark policy action that could help reshape the global HIV response.

14 Jul 2025

Sino Biological sets new industry standard with ProPure™ endotoxin-free proteins made in the USA

Sino Biological US, Inc. proudly unveils ProPure™, an industry-leading line of ultra-pure, endotoxin-free recombinant proteins, fully produced in the USA at its state-of-the-art Center for Bioprocessing (C4B) facility in Houston, Texas.

From Sino Biological Inc. 14 Jul 2025